These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33604285)

  • 1. Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer.
    Zhou X; Li Y; Jiang X; Wang X; Chen S; Shen T; You J; Lu H; Liao H; Li Z; Cheng Z
    Front Oncol; 2020; 10():585213. PubMed ID: 33604285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT.
    Witkowska-Patena E; Budzyńska A; Giżewska A; Dziuk M; Walęcka-Mazur A
    Ann Nucl Med; 2020 Mar; 34(3):192-199. PubMed ID: 31902120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of dual-time point
    Xiao L; Su M; Li Y
    Abdom Radiol (NY); 2024 Sep; 49(9):3214-3219. PubMed ID: 38546825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [
    Uprimny C; Svirydenka A; Fritz J; Kroiss AS; Nilica B; Decristoforo C; Haubner R; von Guggenberg E; Buxbaum S; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1873-1883. PubMed ID: 29766246
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

  • 9. Towards improved diagnosis: radiomics and quantitative biomarkers in 18 F-PSMA-1007 and 18 F-fluorocholine PET/CT for prostate cancer recurrence.
    Panagiotidis E; Andreou S; Paschali A; Angeioplasti K; Vlontzou E; Kalathas T; Pipintakou A; Fothiadaki A; Makridou A; Chatzimarkou M; Papanastasiou E; Datseris I; Chatzipavlidou V
    Nucl Med Commun; 2024 Sep; 45(9):796-803. PubMed ID: 38832429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
    Freitag MT; Radtke JP; Hadaschik BA; Kopp-Schneider A; Eder M; Kopka K; Haberkorn U; Roethke M; Schlemmer HP; Afshar-Oromieh A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):70-83. PubMed ID: 26508290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Heterogeneous Metabolic Patterns of Ganglia in
    Shi Y; Wu JG; Xu L; Zhu Y; Wang Y; Huang G; Liu J; Chen R
    Front Oncol; 2021; 11():666308. PubMed ID: 33968772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of
    Shi Y; Xu L; Zhu Y; Wang Y; Chen R; Liu J
    Front Oncol; 2021; 11():646110. PubMed ID: 33777806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.
    Schoen M; Braun T; Manava P; Ludwigs S; Lell M
    Nuklearmedizin; 2018 Apr; 57(2):50-55. PubMed ID: 29590675
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Uprimny C; Kroiss AS; Decristoforo C; Fritz J; von Guggenberg E; Kendler D; Scarpa L; di Santo G; Roig LG; Maffey-Steffan J; Horninger W; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):941-949. PubMed ID: 28138747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.
    Tsuji S; Iwamoto N; Horai Y; Fujikawa K; Fujita Y; Fukui S; Ideguchi R; Michitsuji T; Nishihata S; Okamoto M; Tsuji Y; Endo Y; Shimizu T; Sumiyoshi R; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kudo T; Kawakami A
    Clin Exp Rheumatol; 2021; 39(6):1338-1344. PubMed ID: 33506750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
    Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
    Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of gallium-68 prostate-specific membrane antigen PET/CT and 2-[18F]fluoro-2-deoxy-D-glucose PET/CT in the detection of thyroid cancer lesions: a prospective head-to-head comparison.
    Shi Y; Feng Y; Xu L; Li W; Guan L; Zuo R; Liu S; Pang H; Wang Z
    Br J Radiol; 2023 Jul; ():. PubMed ID: 38904463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of
    Hoffmann MA; Miederer M; Wieler HJ; Ruf C; Jakobs FM; Schreckenberger M
    Oncotarget; 2017 Dec; 8(67):111073-111083. PubMed ID: 29340038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
    Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
    Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of Radium-223 Dichloride and Early [
    Letellier A; Johnson AC; Kit NH; Savigny JF; Batalla A; Parienti JJ; Aide N
    Mol Imaging Biol; 2018 Jun; 20(3):482-491. PubMed ID: 29027074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.